Publicaciones en las que colabora con LISARDO BOSCA GOMAR (13)

2018

  1. GQ-11: A new PPAR agonist improves obesity-induced metabolic alterations in LDLr-/- mice

    International Journal of Obesity, Vol. 42, Núm. 5, pp. 1062-1072

2016

  1. New PPARγ partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr -/- mice

    Pharmacological Research, Vol. 104, pp. 49-60

2015

  1. A labdane diterpene exerts ex vivo and in vivo cardioprotection against post-ischemic injury: Involvement of AKT-dependent mechanisms

    Biochemical Pharmacology, Vol. 93, Núm. 4, pp. 428-439

  2. New indole-thiazolidine attenuates atherosclerosis in LDLr-/- mice

    Vascular Pharmacology, Vol. 71, pp. 174-180

2013

  1. Critical role of the death receptor pathway in the antitumoral effects induced by hispanolone derivatives

    Oncogene, Vol. 32, Núm. 2, pp. 259-268

2011

  1. Labdane diterpenes protect against anoxia/reperfusion injury in cardiomyocytes: Involvement of AKT activation

    Cell Death and Disease, Vol. 2, Núm. 11

2010

  1. Benznidazole blocks NF-κB activation but not AP-1 through inhibition of IKK

    Molecular Immunology, Vol. 47, Núm. 15, pp. 2485-2491

  2. Electronegative LDL induction of apoptosis in macrophages: Involvement of Nrf2

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1801, Núm. 4, pp. 430-437

2008

  1. Supression of inflammatory responses by labdane-type diterpenoids

    Toxicology and Applied Pharmacology, Vol. 228, Núm. 2, pp. 179-189

2007

  1. Kaurane diterpenes protect against apoptosis and inhibition of phagocytosis in activated macrophages

    British Journal of Pharmacology, Vol. 152, Núm. 2, pp. 249-255

2003

  1. Terpenoids: sources, structure elucidation and therapeutic potential in inflammation.

    Current topics in medicinal chemistry, Vol. 3, Núm. 2, pp. 171-185

2001

  1. Inhibition of the nuclear factor κB (NF-κB) pathway by tetracyclic kaurene diterpenes in macrophages: Specific effects on NF-κB-inducing kinase activity and on the coordinate activation of ERK and p38 MAPK

    Journal of Biological Chemistry, Vol. 276, Núm. 19, pp. 15854-15860

1999

  1. Inhibition of NOS-2 expression in macrophages through the inactivation of NF-κB by andalusol

    British Journal of Pharmacology, Vol. 128, Núm. 3, pp. 605-612